Your Source for BioScience Venture Capital Data
  • OnBioVC NEWS:

    - OnBioVC Announces Beta Launch of Service
    - OnBioVC 3Q11 Trend Analysis, now available
    - OnBioVC 4Q11 Trend Analysis, coming soon
  • SEARCH THE OnBioVC DATABASE:

  • FDA Registered Contract Manufacturer

Benvenue Medical (Mountain View, CA) a commercial stage medical device company focused on minimally invasive solutions of vertebral compression fractures, closed a $35.5M Series C financing. Participants include Domain Associates, Technology Partners, Versant Ventures and DeNovo Ventures.

EndoGastric Solutions (Redmond, WA) a commercial-stage medical device company focused on endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and other GI disorders, closed a $30M Series F financing. Participants have included Canaan Partners, Radius Ventures, Advanced Technology Ventures, Chicago Growth Partners, DeNovo Ventures, Foundation Medical Partners, MPM Capitaland [...]

Spinal Modulation (Menlo Park, CA) a development-stage medical device company focused on a spinal cord stimulator system for treating chronic intractable pain, closed a $27.4M Series C financing. Participants include Johnson & Johnson Development Corp., DFJ InCube Ventures, Raffles Venture Partners, DeNovo Ventures, DFJ ePlanet, Kleiner Perkins Caufield & Byers and MedVenture.
Note: 2009 Year-in-Review Trend [...]

EndoGastric Solutions (Redmond, WA) a commercial-stage medical device company focused on endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and other GI disorders, closed a $21.5M Series E financing. Participants have included Advanced Technology Ventures, Chicago Growth Partners, DeNovo Ventures, Foundation Medical Partners, MPM Capitaland Oakwood Medical Investors.

Note: 2009 [...]

EndoGastric Solutions (Redmond, WA) a commercial-stage medical device company focused on endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and other GI disorders, closed a $21.5 Series E financing. Participants have included Advanced Technology Ventures, Chicago Growth Partners, DeNovo Ventures, Foundation Medical Partners, MPM Capital and Oakwood Medical Investors.
Note: [...]

  

to top of page...